Highlights for the Quarter Y-O-Y:
- Revenue at ₹2,292 million, a growth of 33%
- Domestic Sales grew by 15.5%; aided by relaunches
- Export Sales grew by 144% due to low base
- Profit After Tax was up by 36%
MUMBAI | 28th APRIL 2026 — Sanofi Consumer Healthcare India Limited (BSE:544250 I NSE: SANOFICONR) releases its financial results for the first quarter, demonstrating sustained growth momentum across key business segments. Revenue growth for the quarter stood at 33% year-on-year. Domestic sales grew by 15.5% aided by the relaunch of recalled products to the market.Profit after tax (PAT) for Q1 ‘26reached ₹678 million, an increase of 36% on a year-on-year basis.
Commenting on the Q1’26results, Himanshu Bakshi, Managing Director, Sanofi Consumer Healthcare India Limited, said, “Our performance this quarter reflects consistent, disciplined execution across our key markets. Domestic business outpaced the market, delivering both market share gains and volume growth, while exports made a meaningful contribution to overall results. Guided by science and driven by purpose, we remain committed to simplifying self‑care and making it more accessible and effective for consumers”
